Vadodara: Alembic Pharmaceuticals has strengthened its US generics portfolio with a key regulatory approval, positioning itself to tap into a high-value diabetes treatment market. Alembic ...
Laurie Sepulveda is a MarketWatch Guides team senior writer who specializes in writing about insurance, investing, personal loans, home equity loans, mortgages and banking. She lives in North Carolina ...
Dapagliflozin tablets are indicated to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes. Clobetasol propionate foam is indicated for the treatment of moderate to ...
Arnold Palmer, Tiger Woods, Annika Sörenstam—every great golfer was once a beginner, learning the basics as they picked up their first set of clubs. If you’re ready to take that first swing, we’ve got ...
We spent hours analyzing the best brokers for beginners to find ones that offer low costs, helpful educational content and a broad investment selection. Our testers also looked for trading platforms ...
NEW DELHI: (Apr 16) Alembic Pharmaceuticals Ltd on Thursday said it has received final approval from the US health regulator for its generic version of methotrexate injection used in treatment of ...
Allie is a financial writer and editor with over five years of experience. An investment banker turned journalist, she has previously reported on cryptocurrency for MT Newswires and edited ...
Tijo is an engineer, mechanic, and an avid content creator with over 5 years of experience as an automotive journalist. His media and publishing journey began with CarHP and CarIndigo, and soon ...
The game throws you in right from the start, learning the basics from someone over the comms who has abysmally little belief in you, and so the mining begins. But even with the basics down, everyone ...
One of the biggest hurdles beginning investors must overcome is option overload. With countless investment services, websites and apps to choose from – not to mention the abundance of investments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results